Drugs / Urinary Kallikrein
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04325932 | Jan 2016 → May 2019 | anterior cerebral artery infarction, intracranial arteriosclerosis | Second Affiliated Hospital, School of Medicine, Zhejiang University | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Urinary Kallikrein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04325932 ↗ |